Barclays lowered the firm’s price target on Cemex (CX) to $8 from $9 and keeps an Overweight rating on the shares. The company reported soft Q4 results with operating EBITDA coming in at $747M, well below Barclays’ estimate of $802M, the analyst tells investors in a research note. However, the firm believes most of the negative is priced into the shares.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks